中興商業(000715.SZ):擬向盛東商貿增資
格隆匯 7 月 14日丨中興商業(000715.SZ)公佈,公司擬以自有資金向全資子公司東鄉族自治縣盛東商貿有限公司(“盛東商貿”)增資,由盛東商貿與方大特鋼科技股份有限公司(“方大特鋼”)、甘肅優爾塔農牧業農民專業合作社(“優爾塔合作社”)及甘肅優爾塔電子商務有限公司(“優爾塔電子商務”)共同投資設立合資公司甘肅方大優爾塔牧業發展有限公司(暫定名,以企業登記機關核准名稱為準,“優爾塔牧業”),對甘肅省臨夏州東鄉族自治縣持續實施精準扶貧。
由於公司控股股東遼寧方大集團實業有限公司為方大特鋼的間接控股股東,根據《深圳證券交易所股票上市規則》有關規定,方大特鋼為公司關聯方,此次對外投資事項構成關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.